Bis(2,4-pentanedionato)copper(II) was used as breast cancer therapeutics.
Bis(2,4-pentanedionato)copper(II) was encapsulated into chitosan nanoparticle.
The nanoparticle was targeted to breast cancer cells using her2 receptor and folate receptor.
From in-vivo study, the tumor volume decreased whereas the survivability of mice increased.